HEADER TRANSFERASE 04-JAN-21 7DT2 TITLE STRATEGIC DESIGN OF CATALYTIC LYSINE-TARGETING REVERSIBLE COVALENT TITLE 2 BCR-ABL INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TYROSINE KINASE COVALENT INHIBITOR CHRONIC MYELOGENOUS LEUKEMIA, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.ANANTHARAJAN,N.BABURAJENDRAN REVDAT 3 29-NOV-23 7DT2 1 REMARK REVDAT 2 28-JUL-21 7DT2 1 JRNL REVDAT 1 09-JUN-21 7DT2 0 JRNL AUTH D.QUACH,G.TANG,J.ANANTHARAJAN,N.BABURAJENDRAN,A.POULSEN, JRNL AUTH 2 J.L.K.WEE,P.RETNA,R.LI,B.LIU,D.H.Y.TEE,P.Z.KWEK,J.K.JOY, JRNL AUTH 3 W.Q.YANG,C.J.ZHANG,K.FOO,T.H.KELLER,S.Q.YAO JRNL TITL STRATEGIC DESIGN OF CATALYTIC LYSINE-TARGETING REVERSIBLE JRNL TITL 2 COVALENT BCR-ABL INHIBITORS*. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 60 17131 2021 JRNL REFN ESSN 1521-3773 JRNL PMID 34008286 JRNL DOI 10.1002/ANIE.202105383 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 35900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.570 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.0760 - 5.5409 1.00 2590 154 0.1869 0.2000 REMARK 3 2 5.5409 - 4.3989 1.00 2485 146 0.1735 0.1847 REMARK 3 3 4.3989 - 3.8431 1.00 2458 145 0.1748 0.2068 REMARK 3 4 3.8431 - 3.4918 1.00 2425 143 0.1913 0.2255 REMARK 3 5 3.4918 - 3.2416 1.00 2419 143 0.2081 0.2622 REMARK 3 6 3.2416 - 3.0505 1.00 2427 143 0.2280 0.2689 REMARK 3 7 3.0505 - 2.8977 1.00 2400 141 0.2215 0.2935 REMARK 3 8 2.8977 - 2.7716 1.00 2389 141 0.2248 0.2452 REMARK 3 9 2.7716 - 2.6649 1.00 2373 140 0.2279 0.2518 REMARK 3 10 2.6649 - 2.5730 1.00 2392 141 0.2422 0.2783 REMARK 3 11 2.5730 - 2.4925 1.00 2386 141 0.2409 0.2799 REMARK 3 12 2.4925 - 2.4213 1.00 2391 141 0.2596 0.2925 REMARK 3 13 2.4213 - 2.3575 1.00 2377 141 0.2660 0.3232 REMARK 3 14 2.3575 - 2.3000 1.00 2388 140 0.2815 0.3250 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4408 REMARK 3 ANGLE : 0.561 5973 REMARK 3 CHIRALITY : 0.042 637 REMARK 3 PLANARITY : 0.003 748 REMARK 3 DIHEDRAL : 9.125 2574 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 233 THROUGH 237 OR REMARK 3 (RESID 238 THROUGH 239 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 240 THROUGH 241 OR (RESID 242 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 243 THROUGH 280 REMARK 3 OR (RESID 281 THROUGH 282 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 283 THROUGH 372 OR (RESID 373 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 374 THROUGH 395 REMARK 3 OR (RESID 396 THROUGH 397 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 398 THROUGH 400 OR (RESID 401 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 402 THROUGH 443 REMARK 3 OR (RESID 444 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 445 THROUGH 500)) REMARK 3 SELECTION : (CHAIN B AND (RESID 233 THROUGH 238 OR REMARK 3 (RESID 239 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 240 REMARK 3 THROUGH 273 OR (RESID 274 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 278 THROUGH 307 OR (RESID 308 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 309 THROUGH 333 REMARK 3 OR (RESID 334 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 335 THROUGH 387 OR (RESID 388 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 )) OR RESID 389 THROUGH 461 OR (RESID 462 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 463 THROUGH 466 REMARK 3 OR (RESID 467 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 468 THROUGH 497 OR (RESID 498 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 )) OR RESID 499 THROUGH 500)) REMARK 3 ATOM PAIRS NUMBER : 2378 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7DT2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020029. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95372 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42873 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 49.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.16200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 1.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2QOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1% TRYPTONE, 0.05M HEPES SODIUM PH 7, REMARK 280 20% W/V POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.84600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.15100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.84600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.15100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 201 REMARK 465 GLY A 202 REMARK 465 SER A 203 REMARK 465 SER A 204 REMARK 465 HIS A 205 REMARK 465 HIS A 206 REMARK 465 HIS A 207 REMARK 465 HIS A 208 REMARK 465 HIS A 209 REMARK 465 HIS A 210 REMARK 465 SER A 211 REMARK 465 SER A 212 REMARK 465 GLY A 213 REMARK 465 LEU A 214 REMARK 465 VAL A 215 REMARK 465 PRO A 216 REMARK 465 ARG A 217 REMARK 465 GLY A 218 REMARK 465 SER A 219 REMARK 465 HIS A 220 REMARK 465 MET A 221 REMARK 465 GLU A 222 REMARK 465 ASN A 223 REMARK 465 LEU A 224 REMARK 465 TYR A 225 REMARK 465 PHE A 226 REMARK 465 GLN A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLU A 275 REMARK 465 ASP A 276 REMARK 465 THR A 277 REMARK 465 SER A 501 REMARK 465 ILE A 502 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 MET B 201 REMARK 465 GLY B 202 REMARK 465 SER B 203 REMARK 465 SER B 204 REMARK 465 HIS B 205 REMARK 465 HIS B 206 REMARK 465 HIS B 207 REMARK 465 HIS B 208 REMARK 465 HIS B 209 REMARK 465 HIS B 210 REMARK 465 SER B 211 REMARK 465 SER B 212 REMARK 465 GLY B 213 REMARK 465 LEU B 214 REMARK 465 VAL B 215 REMARK 465 PRO B 216 REMARK 465 ARG B 217 REMARK 465 GLY B 218 REMARK 465 SER B 219 REMARK 465 HIS B 220 REMARK 465 MET B 221 REMARK 465 GLU B 222 REMARK 465 ASN B 223 REMARK 465 LEU B 224 REMARK 465 TYR B 225 REMARK 465 PHE B 226 REMARK 465 GLN B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 ASP B 276 REMARK 465 SER B 501 REMARK 465 ILE B 502 REMARK 465 SER B 503 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 239 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 MET A 388 CG SD CE REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 ILE B 242 CG1 CG2 CD1 REMARK 470 HIS B 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 GLU B 275 CG CD OE1 OE2 REMARK 470 THR B 277 OG1 CG2 REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 GLU B 282 CG CD OE1 OE2 REMARK 470 GLU B 373 CG CD OE1 OE2 REMARK 470 HIS B 396 CG ND1 CD2 CE1 NE2 REMARK 470 PHE B 401 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 444 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 270 CA - C - N ANGL. DEV. = -23.8 DEGREES REMARK 500 VAL A 270 O - C - N ANGL. DEV. = 22.1 DEGREES REMARK 500 LYS A 271 C - N - CA ANGL. DEV. = -24.1 DEGREES REMARK 500 VAL B 270 CA - C - N ANGL. DEV. = -15.2 DEGREES REMARK 500 VAL B 270 O - C - N ANGL. DEV. = 14.4 DEGREES REMARK 500 LYS B 271 C - N - CA ANGL. DEV. = -21.0 DEGREES REMARK 500 LYS B 271 CA - C - N ANGL. DEV. = -24.3 DEGREES REMARK 500 LYS B 271 O - C - N ANGL. DEV. = 22.0 DEGREES REMARK 500 THR B 272 C - N - CA ANGL. DEV. = -17.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -146.42 -132.46 REMARK 500 ARG A 362 -7.87 81.60 REMARK 500 ASP A 363 54.97 -147.93 REMARK 500 LEU A 387 116.68 -163.75 REMARK 500 PRO A 402 99.73 -62.24 REMARK 500 LYS B 245 -145.79 -135.06 REMARK 500 GLU B 279 33.75 -74.19 REMARK 500 ARG B 362 -13.26 84.36 REMARK 500 ASP B 363 57.38 -152.33 REMARK 500 THR B 389 -56.49 -132.97 REMARK 500 PRO B 402 103.33 -59.92 REMARK 500 LYS B 454 33.28 -96.37 REMARK 500 REMARK 500 REMARK: NULL DBREF 7DT2 A 229 510 UNP P00519 ABL1_HUMAN 229 510 DBREF 7DT2 B 229 510 UNP P00519 ABL1_HUMAN 229 510 SEQADV 7DT2 MET A 201 UNP P00519 INITIATING METHIONINE SEQADV 7DT2 GLY A 202 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 203 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 204 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 205 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 206 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 207 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 208 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 209 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 210 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 211 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 212 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLY A 213 UNP P00519 EXPRESSION TAG SEQADV 7DT2 LEU A 214 UNP P00519 EXPRESSION TAG SEQADV 7DT2 VAL A 215 UNP P00519 EXPRESSION TAG SEQADV 7DT2 PRO A 216 UNP P00519 EXPRESSION TAG SEQADV 7DT2 ARG A 217 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLY A 218 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 219 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS A 220 UNP P00519 EXPRESSION TAG SEQADV 7DT2 MET A 221 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLU A 222 UNP P00519 EXPRESSION TAG SEQADV 7DT2 ASN A 223 UNP P00519 EXPRESSION TAG SEQADV 7DT2 LEU A 224 UNP P00519 EXPRESSION TAG SEQADV 7DT2 TYR A 225 UNP P00519 EXPRESSION TAG SEQADV 7DT2 PHE A 226 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLN A 227 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER A 228 UNP P00519 EXPRESSION TAG SEQADV 7DT2 MET B 201 UNP P00519 INITIATING METHIONINE SEQADV 7DT2 GLY B 202 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 203 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 204 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 205 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 206 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 207 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 208 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 209 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 210 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 211 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 212 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLY B 213 UNP P00519 EXPRESSION TAG SEQADV 7DT2 LEU B 214 UNP P00519 EXPRESSION TAG SEQADV 7DT2 VAL B 215 UNP P00519 EXPRESSION TAG SEQADV 7DT2 PRO B 216 UNP P00519 EXPRESSION TAG SEQADV 7DT2 ARG B 217 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLY B 218 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 219 UNP P00519 EXPRESSION TAG SEQADV 7DT2 HIS B 220 UNP P00519 EXPRESSION TAG SEQADV 7DT2 MET B 221 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLU B 222 UNP P00519 EXPRESSION TAG SEQADV 7DT2 ASN B 223 UNP P00519 EXPRESSION TAG SEQADV 7DT2 LEU B 224 UNP P00519 EXPRESSION TAG SEQADV 7DT2 TYR B 225 UNP P00519 EXPRESSION TAG SEQADV 7DT2 PHE B 226 UNP P00519 EXPRESSION TAG SEQADV 7DT2 GLN B 227 UNP P00519 EXPRESSION TAG SEQADV 7DT2 SER B 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 310 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 310 LEU VAL PRO ARG GLY SER HIS MET GLU ASN LEU TYR PHE SEQRES 3 A 310 GLN SER SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG SEQRES 4 A 310 THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN SEQRES 5 A 310 TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER SEQRES 6 A 310 LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET SEQRES 7 A 310 GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS SEQRES 8 A 310 GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL SEQRES 9 A 310 CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE SEQRES 10 A 310 MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS SEQRES 11 A 310 ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET SEQRES 12 A 310 ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS SEQRES 13 A 310 LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 A 310 LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE SEQRES 15 A 310 GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA SEQRES 16 A 310 HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO SEQRES 17 A 310 GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP SEQRES 18 A 310 VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR SEQRES 19 A 310 TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN SEQRES 20 A 310 VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG SEQRES 21 A 310 PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG SEQRES 22 A 310 ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE SEQRES 23 A 310 ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SEQRES 24 A 310 SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU SEQRES 1 B 310 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 310 LEU VAL PRO ARG GLY SER HIS MET GLU ASN LEU TYR PHE SEQRES 3 B 310 GLN SER SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG SEQRES 4 B 310 THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN SEQRES 5 B 310 TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER SEQRES 6 B 310 LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET SEQRES 7 B 310 GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS SEQRES 8 B 310 GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL SEQRES 9 B 310 CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE SEQRES 10 B 310 MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS SEQRES 11 B 310 ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET SEQRES 12 B 310 ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS SEQRES 13 B 310 LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 B 310 LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE SEQRES 15 B 310 GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA SEQRES 16 B 310 HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO SEQRES 17 B 310 GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP SEQRES 18 B 310 VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR SEQRES 19 B 310 TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN SEQRES 20 B 310 VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG SEQRES 21 B 310 PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG SEQRES 22 B 310 ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE SEQRES 23 B 310 ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SEQRES 24 B 310 SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU HET HJ9 A 601 32 HET HJ9 B 601 32 HETNAM HJ9 [4-[5-[5-(DIMETHYLCARBAMOYL)PYRIDIN-3-YL]-1H-PYRROLO[2, HETNAM 2 HJ9 3-B]PYRIDIN-3-YL]-2-METHANOYL-5-METHOXY-PHENYL]BORONIC HETNAM 3 HJ9 ACID FORMUL 3 HJ9 2(C23 H21 B N4 O5) FORMUL 5 HOH *164(H2 O) HELIX 1 AA1 GLU A 238 THR A 240 5 3 HELIX 2 AA2 GLY A 249 GLN A 252 5 4 HELIX 3 AA3 LYS A 263 SER A 265 5 3 HELIX 4 AA4 GLU A 279 GLU A 292 1 14 HELIX 5 AA5 ASN A 322 CYS A 330 1 9 HELIX 6 AA6 ASN A 336 LYS A 357 1 22 HELIX 7 AA7 ALA A 365 ARG A 367 5 3 HELIX 8 AA8 GLU A 373 HIS A 375 5 3 HELIX 9 AA9 PRO A 402 THR A 406 5 5 HELIX 10 AB1 ALA A 407 ASN A 414 1 8 HELIX 11 AB2 SER A 417 THR A 434 1 18 HELIX 12 AB3 ASP A 444 SER A 446 5 3 HELIX 13 AB4 GLN A 447 LYS A 454 1 8 HELIX 14 AB5 PRO A 465 TRP A 476 1 12 HELIX 15 AB6 ASN A 479 ARG A 483 5 5 HELIX 16 AB7 SER A 485 GLU A 499 1 15 HELIX 17 AB8 GLU B 238 THR B 240 5 3 HELIX 18 AB9 GLY B 249 GLN B 252 5 4 HELIX 19 AC1 LYS B 263 SER B 265 5 3 HELIX 20 AC2 GLU B 279 GLU B 292 1 14 HELIX 21 AC3 ASN B 322 CYS B 330 1 9 HELIX 22 AC4 ASN B 336 LYS B 357 1 22 HELIX 23 AC5 ALA B 365 ARG B 367 5 3 HELIX 24 AC6 GLU B 373 HIS B 375 5 3 HELIX 25 AC7 PRO B 402 THR B 406 5 5 HELIX 26 AC8 ALA B 407 ASN B 414 1 8 HELIX 27 AC9 ILE B 418 THR B 434 1 17 HELIX 28 AD1 ASP B 444 SER B 446 5 3 HELIX 29 AD2 GLN B 447 LYS B 454 1 8 HELIX 30 AD3 PRO B 465 TRP B 476 1 12 HELIX 31 AD4 ASN B 479 ARG B 483 5 5 HELIX 32 AD5 SER B 485 GLU B 499 1 15 SHEET 1 AA1 5 ILE A 242 LYS A 247 0 SHEET 2 AA1 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 AA1 5 LEU A 266 THR A 272 -1 O VAL A 270 N TYR A 257 SHEET 4 AA1 5 TYR A 312 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 AA1 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 AA2 2 PHE A 359 ILE A 360 0 SHEET 2 AA2 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 AA3 2 CYS A 369 VAL A 371 0 SHEET 2 AA3 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 AA4 2 TYR A 393 THR A 394 0 SHEET 2 AA4 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 AA5 5 ILE B 242 LYS B 247 0 SHEET 2 AA5 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 AA5 5 LEU B 266 THR B 272 -1 O VAL B 268 N GLY B 259 SHEET 4 AA5 5 TYR B 312 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 5 AA5 5 LEU B 301 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 AA6 2 PHE B 359 ILE B 360 0 SHEET 2 AA6 2 SER B 385 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 AA7 2 CYS B 369 VAL B 371 0 SHEET 2 AA7 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 AA8 2 THR B 392 THR B 394 0 SHEET 2 AA8 2 LYS B 415 SER B 417 -1 O PHE B 416 N TYR B 393 LINK NZ LYS A 271 C21 HJ9 A 601 1555 1555 1.28 LINK NZ LYS B 271 C21 HJ9 B 601 1555 1555 1.28 CISPEP 1 PRO A 309 PRO A 310 0 -3.99 CISPEP 2 PRO B 309 PRO B 310 0 -3.70 CRYST1 105.692 132.302 56.344 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009461 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007558 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017748 0.00000